Clinical Trials Logo
  1. Home
  2. Dedifferentiated Liposarcoma
  3. NCT05496569

TQB3616 Capsules in the Treatment of Dedifferentiated Liposarcoma

Dedifferentiated Liposarcoma Clinical Trial

Official title:
A Randomized, Double-blind, Placebo-controlled, Multicenter Phase II Clinical Trial of TQB3616 Capsules Versus Placebo in the Treatment of Dedifferentiated Liposarcoma

Clinical Trial Summary

A clinical trial evaluating TQB3616 capsules versus placebo in the treatment of dedifferentiated liposarcoma. Divided into 2 stages, the second stage, a total of 118 subjects are planned to be enrolled.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05496569
Study type Interventional
Source Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Contact Yuhong Zhou, Doctor
Phone 021-64041990
Email Zhou.yuhong@zshospital.sh.cn
Status Not yet recruiting
Phase Phase 2
Start date December 2022
Completion date December 2024
View Details
See also
  Status Clinical Trial Phase
Active, not recruiting NCT03307616 - Nivolumab With and Without Ipilimumab and Radiation Therapy in Treating Patients With Recurrent or Resectable Undifferentiated Pleomorphic Sarcoma or Dedifferentiated Liposarcoma Before Surgery Phase 2
Completed NCT01913652 - Ph II Cabazitaxel DD Liposarcoma Phase 2
Not yet recruiting NCT06389799 - A Phase 2, Open Label Study of PEmigatinib and REtifanlimab in Advanced Dedifferentiated LIposarcoma (PERELI) Phase 2
Recruiting NCT05886634 - A Study of Etrumadenant and Zimberelimab in People With Dedifferentiated Liposarcoma Phase 2
Active, not recruiting NCT06115681 - Real-world Study of Dedifferentiated Liposarcoma Patients in China
Active, not recruiting NCT02846987 - Study of Abemaciclib in Dedifferentiated Liposarcoma Phase 2
Terminated NCT04979442 - Treatment of Milademetan Versus Trabectedin in Patient With Dedifferentiated Liposarcoma Phase 3
Completed NCT02606461 - Selinexor in Advanced Liposarcoma Phase 2/Phase 3
Active, not recruiting NCT04242238 - Study of DCC-3014 in Combination With Avelumab in Patients With Advanced or Metastatic Sarcomas Phase 1
Withdrawn NCT00969917 - Study Evaluating the Efficacy and Safety of IPI 504 in Patients With Advanced Dedifferentiated Liposarcoma Phase 2
Active, not recruiting NCT03651375 - Hypofractionated Radiotherapy With Sequential Chemotherapy in Marginally Resectable Soft Tissue Sarcomas of Extremities or Trunk Wall Phase 2
Terminated NCT03604783 - Phase 1, First-in-human Study of Oral TP-1287 in Patients With Advanced Solid Tumors Phase 1